MetLife (MET) Hisse Özeti
Bir finansal hizmetler şirketi olan MetLife, Inc. dünya çapında sigorta, yıllık gelirler, çalışanlara sağlanan faydalar ve varlık yönetimi hizmetleri sunmaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 2/6 |
| Gelecekteki Büyüme | 1/6 |
| Geçmiş Performans | 1/6 |
| Finansal Sağlık | 3/6 |
| Temettüler | 5/6 |
MET Community Fair Values
Create NarrativeSee what 48 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
MetLife, Inc. Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | US$84.06 |
| 52 Haftanın En Yüksek Seviyesi | US$85.29 |
| 52 Haftanın En Düşük Seviyesi | US$67.33 |
| Beta | 0.77 |
| 1 Aylık Değişim | 8.19% |
| 3 Aylık Değişim | 11.62% |
| 1 Yıllık Değişim | 6.36% |
| 3 Yıllık Değişim | 62.75% |
| 5 Yıllık Değişim | 26.39% |
| Halka arzdan bu yana değişim | 469.90% |
Son Haberler & Güncellemeler
Seeking Alpha • May 24
MetLife: Time To Go Long The Common Shares And 6.35% Yielding Preferreds
Summary MetLife delivers robust adjusted income, supporting a bullish stance on common shares and fixed-rate preferreds. MET's preferred dividend payout ratio remains low, with $24.5B in common equity providing strong downside protection for preferred holders. Series A floating-rate preferreds yield 5.45%-5.5%, attractive if short-term rates rise, but fixed-rate Series F offers a higher current yield. I rate MET common and Series F preferreds as a "buy," maintaining "hold" on Series A preferreds pending a significant SOFR increase. Read the full article on Seeking Alpha
Anlatı Güncellemesi • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.Recent updates
Seeking Alpha • May 24
MetLife: Time To Go Long The Common Shares And 6.35% Yielding Preferreds
Summary MetLife delivers robust adjusted income, supporting a bullish stance on common shares and fixed-rate preferreds. MET's preferred dividend payout ratio remains low, with $24.5B in common equity providing strong downside protection for preferred holders. Series A floating-rate preferreds yield 5.45%-5.5%, attractive if short-term rates rise, but fixed-rate Series F offers a higher current yield. I rate MET common and Series F preferreds as a "buy," maintaining "hold" on Series A preferreds pending a significant SOFR increase. Read the full article on Seeking AlphaAnlatı Güncellemesi • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.Anlatı Güncellemesi • Apr 17
MET: Share Repurchases Following Index Exit Will Support Future Upside Potential
Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).Anlatı Güncellemesi • Apr 01
MET: Share Repurchases And Index Exit Will Shape Future Upside Potential
Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.Anlatı Güncellemesi • Mar 18
MET: Share Repurchases Will Support Future Upside Potential
Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).Anlatı Güncellemesi • Mar 04
MET: Buybacks And Retirement Income Agreements Will Drive Future Upside
Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.Anlatı Güncellemesi • Dec 16
MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power
Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.Anlatı Güncellemesi • Nov 07
MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements
Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.Anlatı Güncellemesi • Oct 24
Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead
Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.Anlatı Güncellemesi • Oct 09
International Demand And Digital Transformation Will Fuel Success
Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.Anlatı Güncellemesi • Sep 04
International Demand And Digital Transformation Will Fuel Success
With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.Analiz Makalesi • Jun 11
It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year
Key Insights MetLife's Annual General Meeting to take place on 17th of June Salary of US$1.50m is part of CEO Michel...Seeking Alpha • Feb 11
MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking AlphaSeeking Alpha • Nov 26
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking AlphaSeeking Alpha • Sep 23
MetLife: One Of The Best Life Insurance Stocks
Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking AlphaSeeking Alpha • Jul 09
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking AlphaSeeking Alpha • Jun 26
MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking AlphaSeeking Alpha • Apr 18
MetLife: Healthy But Lacks Clear Advantages
Summary MetLife has experienced a decade of light shrinking instead of growth. This started as early as 2015 and was attributed to increased competition and a decrease in annuity sales, but this never seemed to improve. With their current size, competitive hurdles, and lack of clear targets for growth internationally, shares of MET will likely only give mediocre returns at best. Read the full article on Seeking AlphaHissedar Getirileri
| MET | US Insurance | US Pazar | |
|---|---|---|---|
| 7D | 3.7% | -0.6% | 1.2% |
| 1Y | 6.4% | -6.7% | 28.7% |
Getiri vs. Endüstri: MET geçen yıl % -6.7 oranında getiri sağlayan US Insurance sektörünü aştı.
Getiri vs Piyasa: MET geçen yıl % 28.7 oranında getiri sağlayan US Piyasasının altında performans gösterdi.
Fiyat Oynaklığı
| MET volatility | |
|---|---|
| MET Average Weekly Movement | 3.4% |
| Insurance Industry Average Movement | 4.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
İstikrarlı Hisse Senedi Fiyatı: MET son 3 ayda US piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: MET 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1999 | 46,000 | Michel Khalaf | www.metlife.com |
Bir finansal hizmetler şirketi olan MetLife, Inc. dünya çapında sigorta, yıllık gelirler, çalışanlara sağlanan faydalar ve varlık yönetimi hizmetleri sunmaktadır. Altı segmentte faaliyet göstermektedir: Grup Faydaları; Emeklilik ve Gelir Çözümleri; Asya; Latin Amerika; Avrupa, Orta Doğu ve Afrika; ve MetLife Holdings. Şirket, hayat, diş, grup kısa ve uzun süreli maluliyet, ücretli aile ve tıbbi izin, bireysel maluliyet, kaza sonucu ölüm ve parçalanma, kaza ve sağlık, görme ve evcil hayvan sigortalarının yanı sıra ön ödemeli yasal planlar; işverenlere yalnızca idari hizmet düzenlemeleri; genel ve ayrı hesap ve sentetik garantili faiz sözleşmelerinin yanı sıra özel değişken oranlı fonlama anlaşmaları sunmaktadır.
MetLife, Inc. Temel Bilgiler Özeti
| MET temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | US$54.09b |
| Kazançlar(TTM) | US$3.43b |
| Gelir(TTM) | US$77.58b |
15.8x
F/K Oranı0.7x
P/S OranıMET aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| MET gelir tablosu (TTM) | |
|---|---|
| Gelir | US$77.58b |
| Gelir Maliyeti | US$59.15b |
| Brüt Kâr | US$18.43b |
| Diğer Giderler | US$15.00b |
| Kazançlar | US$3.43b |
Son Raporlanan Kazançlar
Mar 31, 2026
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | 5.34 |
| Brüt Marj | 23.75% |
| Net Kâr Marjı | 4.43% |
| Borç/Özkaynak Oranı | 178.0% |
MET uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünTemettüler
2.7%
Mevcut Temettü Verimi44%
Ödeme OranıMET güvenilir bir temettü ödüyor mu?
MET temettü geçmişine ve kıyaslamalara bakın| MetLife temettü tari̇hleri̇ | |
|---|---|
| Eski Temettü Tarihi | May 12 2026 |
| Temettü Ödeme Tarihi | Jun 09 2026 |
| Eski temettüye kadar geçen günler | 15 days |
| Temettü ödeme tarihine kadar geçen günler | 13 days |
MET güvenilir bir temettü ödüyor mu?
MET temettü geçmişine ve kıyaslamalara bakınŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/26 15:36 |
| Gün Sonu Hisse Fiyatı | 2026/05/22 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
MetLife, Inc. 32 Bu analistlerden 9, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Gelb | Barclays |
| Taylor Scott | Barclays |